Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Methanol Pure Play 'Attractive,' Share Price 'Too Punitive'

The leverage Methanex Corp. could use to still pay its dividend in a low price environment is discussed in a BMO Capital Markets report. In a March 17 research note, BMO Capital Markets analyst Joel Jackson reported that Methanex Corp. (MEOH:NASDAQ; MX:TSX;...

Buzz on the Bullboards: Three newsmakers during TSX’s rebound

The TSX experienced a roller-coaster week, starting with notable losses but ending with a robust rebound, leading to significant gains. This positive shift has supported investor confidence, proving that it is important to stay updated with recent developments. Let&CloseC...

Gold Miners Will Rush to this New Cost-Saving Tech

(Image via EnviroLeach Technologies Inc.) New technology is emerging as a potential standard to address two market sectors totaling $193 billion, through eco-friendly methods for the hydrometallurgical extraction of precious metals …. Pioneered by EnviroLe...

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer. Clinical-stage biopharmaceutical company Mersana Therapeuti...

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...

Buzz on the Bullboards: Don’t Get Spooked by these Market Performers

There is nothing scarier on Hallowe’en than an uncertain stock market. Lately, this is exactly what investors have been dealing with and part of what we try to demystify at Stockhouse. There have been many companies moving independent of the market...

Visiting the Zinc8 Energy Storage Development and Production Facility

The Dawn of the Utility-Scale Battery Era Following the latest press-releases and positive media coverage on the Collaboration Agreement between Zinc8 Energy Solutions Inc. and the New York Power Authority (NYPA) to deploy a 100kW/1MWh energy storage system in New...